BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24469360)

  • 1. Association between cyclooxygenase-2 gene polymorphisms and head and neck squamous cell carcinoma risk.
    Niu Y; Yuan H; Shen M; Li H; Hu Y; Chen N
    J Craniofac Surg; 2014 Mar; 25(2):333-7. PubMed ID: 24469360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variants in AKT1 gene were associated with risk and survival of OSCC in Chinese Han Population.
    Wang Y; Lin L; Xu H; Li T; Zhou Y; Dan H; Jiang L; Liao G; Zhou M; Li L; Zeng X; Li J; Chen Q
    J Oral Pathol Med; 2015 Jan; 44(1):45-50. PubMed ID: 25060489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-nucleotide polymorphisms in DNA double-strand break repair genes: association with head and neck cancer and interaction with tobacco use and alcohol consumption.
    Werbrouck J; De Ruyck K; Duprez F; Van Eijkeren M; Rietzschel E; Bekaert S; Vral A; De Neve W; Thierens H
    Mutat Res; 2008 Oct; 656(1-2):74-81. PubMed ID: 18768166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COX-2 rs689466, rs5275, and rs20417 polymorphisms and risk of head and neck squamous cell carcinoma: a meta-analysis of adjusted and unadjusted data.
    Leng WD; Wen XJ; Kwong JSW; Huang W; Chen JG; Zeng XT
    BMC Cancer; 2016 Jul; 16():457. PubMed ID: 27412115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of XRCC1 gene polymorphisms in Turkish head and neck squamous cell carcinoma patients: a comparative analysis with different populations.
    Mutlu P; Mutlu M; Yalcin S; Unsoy G; Yaylaci A; Saylam G; Akin I; Korkmaz H; Gunduz U
    J BUON; 2015; 20(2):540-7. PubMed ID: 26011347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of OX40 gene polymorphisms (rs17568G/A and rs229811A/C) with head and neck squamous cell carcinoma.
    Faghih Z; Abtahi S; Khademi B; Nikfarjam F; Erfani N
    Mol Biol Rep; 2019 Jun; 46(3):2609-2616. PubMed ID: 30923998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Association between genetic variants in microRNA biosynthesis genes and the risk of head and neck squamous cell carcinoma].
    Yuan WW; Hang D; Wang LH; Chen SH; Ding ZX; Hu ZB; Ma HX
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Aug; 37(8):1069-73. PubMed ID: 27539334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of potentially functional polymorphisms in suppressor of cytokine signaling 3 (SOCS3) on the risk of head and neck squamous cancer.
    Hang D; Yin Y; Wang L; Yuan H; Du J; Zhu M; Dai J; Chen N; Hu Z; Shen H; Ma H
    J Oral Pathol Med; 2017 Sep; 46(8):598-602. PubMed ID: 27977878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SNP rs1049430 in the 3'-UTR of SH3GL2 regulates its expression: Clinical and prognostic implications in head and neck squamous cell carcinoma.
    Maiti GP; Ghosh A; Mondal P; Baral A; Datta S; Samadder S; Nayak SP; Chakrabarti J; Biswas J; Sikdar N; Chowdhury S; Roy B; Roychowdhury S; Panda CK
    Biochim Biophys Acta; 2015 May; 1852(5):1059-67. PubMed ID: 25728707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase-2-1195G>A Polymorphism and Head and Neck Squamous Cell Carcinoma Susceptibility: A Meta-Analysis of 1564 Cases and 2346 Controls.
    Deng DL; Xia LY; He BY; Guo JM; Huang C; Zeng XT
    Med Sci Monit; 2015 Nov; 21():3514-20. PubMed ID: 26568042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-101 polymorphisms and risk of head and neck squamous cell carcinoma in a Chinese population.
    Miao L; Wang L; Yuan H; Hang D; Zhu L; Du J; Zhu X; Li B; Wang R; Ma H; Chen N
    Tumour Biol; 2016 Mar; 37(3):4169-74. PubMed ID: 26490987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The axis inhibition protein 2 polymorphisms and non-syndromic orofacial clefts susceptibility in a Chinese Han population.
    Han Y; Zhou L; Ma L; Li D; Xu M; Yuan H; Ma J; Zhang W; Jiang H; Wu Y; Wang L; Pan Y
    J Oral Pathol Med; 2014 Aug; 43(7):554-60. PubMed ID: 24484320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in alcohol and tobacco metabolism genes in head and neck cancer in the Basque Country.
    Bediaga NG; Marichalar-Mendia X; Rey-Barja N; Setien-Olarra A; Gonzalez-Garcia JA; de Pancorbo MM; Aguirre-Urizar JM; Acha-Sagredo A
    J Oral Pathol Med; 2015 Nov; 44(10):769-75. PubMed ID: 25639971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter polymorphisms of DNMT3B and the risk of head and neck squamous cell carcinoma in Taiwan: a case-control study.
    Chang KP; Hao SP; Liu CT; Cheng MH; Chang YL; Lee YS; Wang TH; Tsai CN
    Oral Oncol; 2007 Apr; 43(4):345-51. PubMed ID: 16920385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Head and neck squamous cell carcinoma is not associated with interleukin-18 promoter gene polymorphisms: a case-control study.
    Asefi V; Mojtahedi Z; Khademi B; Naeimi S; Ghaderi A
    J Laryngol Otol; 2009 Apr; 123(4):444-8. PubMed ID: 18940019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KIT polymorphisms were associated with the risk for head and neck squamous carcinoma in Chinese population.
    Hang D; Yuan H; Liu L; Wang L; Miao L; Zhu M; Du J; Dai J; Hu Z; Chen N; Shen H; Ma H
    Mol Carcinog; 2017 Jan; 56(1):232-237. PubMed ID: 27186940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of two BRM promoter polymorphisms with head and neck squamous cell carcinoma risk.
    Wang JR; Gramling SJ; Goldstein DP; Cheng D; Chen D; Azad AK; Tse A; Hon H; Chen Z; Mirshams M; Simpson C; Huang SH; Marquez S; O'Sullivan B; Liu FF; Roberts H; Xu W; Brown DH; Gilbert RW; Gullane PJ; Irish JC; Reisman DN; Liu G
    Carcinogenesis; 2013 May; 34(5):1012-7. PubMed ID: 23322154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined effect of tobacco and DNA repair genes polymorphisms of XRCC1 and XRCC2 influence high risk of head and neck squamous cell carcinoma in northeast Indian population.
    Choudhury JH; Choudhury B; Kundu S; Ghosh SK
    Med Oncol; 2014 Aug; 31(8):67. PubMed ID: 24958516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in drug-metabolizing enzymes and risk to head and neck cancer: evidence for gene-gene and gene-environment interaction.
    Maurya SS; Anand G; Dhawan A; Khan AJ; Jain SK; Pant MC; Parmar D
    Environ Mol Mutagen; 2014 Mar; 55(2):134-44. PubMed ID: 24519899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene-environment interaction and susceptibility in head and neck cancer patients and in their first-degree relatives: a study of Northeast Indian population.
    Choudhury JH; Ghosh SK
    J Oral Pathol Med; 2015 Aug; 44(7):495-501. PubMed ID: 25167831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.